Vyome Holdings, Inc. (NASDAQ:HIND) Short Interest Update

Vyome Holdings, Inc. (NASDAQ:HIND) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 260,650 shares, an increase of 220.8% from the January 15th total of 81,249 shares. Approximately 6.9% of the company’s shares are sold short. Based on an average trading volume of 4,310,075 shares, the days-to-cover ratio is currently 0.1 days. Based on an average trading volume of 4,310,075 shares, the days-to-cover ratio is currently 0.1 days. Approximately 6.9% of the company’s shares are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e-)” rating on shares of Vyome in a report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $15.00.

Institutional Trading of Vyome

A hedge fund recently bought a new stake in Vyome stock. Geode Capital Management LLC acquired a new stake in shares of Vyome Holdings, Inc. (NASDAQ:HIND) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 11,934 shares of the company’s stock, valued at approximately $41,000. Geode Capital Management LLC owned approximately 0.21% of Vyome at the end of the most recent quarter. Institutional investors own 22.06% of the company’s stock.

Vyome Price Performance

Vyome stock traded down $0.01 during midday trading on Wednesday, reaching $2.56. The stock had a trading volume of 140,948 shares, compared to its average volume of 1,813,322. The company has a market cap of $14.45 million, a P/E ratio of -0.02 and a beta of 1.50. Vyome has a 12 month low of $1.75 and a 12 month high of $305.00. The business has a fifty day moving average price of $3.44.

Vyome (NASDAQ:HIND) last posted its quarterly earnings results on Friday, November 14th. The company reported ($3.12) earnings per share (EPS) for the quarter. Vyome had a negative net margin of 270.58% and a negative return on equity of 423.39%. The business had revenue of $0.04 million during the quarter.

Vyome Company Profile

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.